Tallan Blog

Tallan’s Experts Share Their Knowledge on Technology, Trends and Solutions to Business Challenges

Tallan Client Abiomed Featured on CNBC for Innovation in Medical Technology

Source: CNBC.COM

Source: CNBC.com

We are incredibly impressed by the innovation our client, Abiomed continues to deliver and are humbled to be a part of this life-saving solution.

The Food and Drug Administration has approved the emergency use of Abiomed’s Impella heart pump to help treat Covid-19 patients suffering from heart and lung failure, the company announced Tuesday.

In 1 in 10 patients, the virus results in extreme inflammation of the heart, in addition to a build-up of fluid in the lungs. For 42-year-old Devan Smith, who had no history of heart disease, the combination proved nearly fatal in May. (CNBC.com)

To read full article, click here.

 

 

Share this post:
Tags: covid19, data, impella,

No comments

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

\\\